In turn, this promotes cancer cell growth [76], [77], invasion [78] and apoptosis resistance [79], [80] and thus PI3K and Akt have emerged as key targets for the development of novel anti-cancer therapeutics [81], [82]. The gene discussed is PIK3CA; the disease is cancer.